Jung-Hsin Hsu

1.2k total citations
15 papers, 1.0k citations indexed

About

Jung-Hsin Hsu is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Jung-Hsin Hsu has authored 15 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Hematology and 3 papers in Oncology. Recurrent topics in Jung-Hsin Hsu's work include PI3K/AKT/mTOR signaling in cancer (6 papers), Multiple Myeloma Research and Treatments (5 papers) and Cytokine Signaling Pathways and Interactions (3 papers). Jung-Hsin Hsu is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (6 papers), Multiple Myeloma Research and Treatments (5 papers) and Cytokine Signaling Pathways and Interactions (3 papers). Jung-Hsin Hsu collaborates with scholars based in United States and Taiwan. Jung-Hsin Hsu's co-authors include Yijiang Shi, Alan Lichtenstein, Joseph Gera, Liping Hu, Chris Tran, Ingo K. Mellinghoff, Charles L. Sawyers, Matthew B. Rettig, Gregory A. Brent and Myrna Fisher and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Oncogene.

In The Last Decade

Jung-Hsin Hsu

15 papers receiving 987 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jung-Hsin Hsu United States 11 800 264 219 169 110 15 1.0k
Verónica Ayllón Spain 23 1.1k 1.4× 209 0.8× 171 0.8× 67 0.4× 180 1.6× 42 1.4k
Nilamani Jena United States 9 806 1.0× 137 0.5× 339 1.5× 78 0.5× 114 1.0× 13 1.2k
Ricardo López‐Pérez Spain 18 614 0.8× 448 1.7× 222 1.0× 104 0.6× 90 0.8× 36 1.0k
Roberto Bellelli United Kingdom 16 1.1k 1.3× 106 0.4× 283 1.3× 55 0.3× 245 2.2× 23 1.3k
José F. Ruiz Spain 17 1.0k 1.3× 139 0.5× 171 0.8× 66 0.4× 377 3.4× 29 1.4k
Michael B. Dilling United States 8 876 1.1× 60 0.2× 301 1.4× 156 0.9× 143 1.3× 8 1.1k
Frédéric Zilbermann Switzerland 7 896 1.1× 72 0.3× 228 1.0× 93 0.6× 122 1.1× 8 1.1k
Hoanh Tran United States 16 1.1k 1.3× 60 0.2× 282 1.3× 73 0.4× 225 2.0× 21 1.5k
Thamar B. van Dijk Netherlands 22 867 1.1× 150 0.6× 471 2.2× 63 0.4× 162 1.5× 36 1.5k
Gabriel Bretones Spain 16 761 1.0× 68 0.3× 323 1.5× 112 0.7× 181 1.6× 24 1.1k

Countries citing papers authored by Jung-Hsin Hsu

Since Specialization
Citations

This map shows the geographic impact of Jung-Hsin Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jung-Hsin Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jung-Hsin Hsu more than expected).

Fields of papers citing papers by Jung-Hsin Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jung-Hsin Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jung-Hsin Hsu. The network helps show where Jung-Hsin Hsu may publish in the future.

Co-authorship network of co-authors of Jung-Hsin Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Jung-Hsin Hsu. A scholar is included among the top collaborators of Jung-Hsin Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jung-Hsin Hsu. Jung-Hsin Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Hsu, Jung-Hsin, et al.. (2015). Yam storage protein dioscorins modulate cytokine gene expression in BALB/c and C57BL/6 lymphocytes. Food and Agricultural Immunology. 26(6). 909–923. 5 indexed citations
2.
Chen, Jinan, et al.. (2015). Cyclophilin A as a downstream effector of PI3K/Akt signalling pathway in multiple myeloma cells. Cell Biochemistry and Function. 33(8). 566–574. 5 indexed citations
3.
Ho, Yen‐Peng, et al.. (2013). Inhibition of aldolase A blocks biogenesis of ATP and attenuates Japanese encephalitis virus production. Biochemical and Biophysical Research Communications. 443(2). 464–469. 11 indexed citations
4.
Ho, Yen‐Peng, et al.. (2010). β-Actin is a downstream effector of the PI3K/AKT signaling pathway in myeloma cells. Molecular and Cellular Biochemistry. 348(1-2). 129–139. 15 indexed citations
5.
Hsu, Jung-Hsin, Yijiang Shi, Patrick Frost, et al.. (2004). Interleukin-6 activates phosphoinositol-3′ kinase in multiple myeloma tumor cells by signaling through RAS-dependent and, separately, through p85-dependent pathways. Oncogene. 23(19). 3368–3375. 49 indexed citations
6.
Gera, Joseph, Ingo K. Mellinghoff, Yijiang Shi, et al.. (2004). AKT Activity Determines Sensitivity to Mammalian Target of Rapamycin (mTOR) Inhibitors by Regulating Cyclin D1 and c-myc Expression. Journal of Biological Chemistry. 279(4). 2737–2746. 284 indexed citations
7.
Hsu, Jung-Hsin, Yijiang Shi, Liping Hu, et al.. (2002). Role of the AKT kinase in expansion of multiple myeloma clones: effects on cytokine-dependent proliferative and survival responses. Oncogene. 21(9). 1391–1400. 69 indexed citations
8.
Shi, Yijiang, Jung-Hsin Hsu, Liping Hu, Joseph Gera, & Alan Lichtenstein. (2002). Signal Pathways Involved in Activation of p70S6K and Phosphorylation of 4E-BP1 following Exposure of Multiple Myeloma Tumor Cells to Interleukin-6. Journal of Biological Chemistry. 277(18). 15712–15720. 96 indexed citations
9.
Shi, Yijiang, Joseph Gera, Liping Hu, et al.. (2002). Enhanced sensitivity of multiple myeloma cells containing PTEN mutations to CCI-779.. PubMed. 62(17). 5027–34. 198 indexed citations
10.
Hsu, Jung-Hsin, Yijiang Shi, Liping Hu, et al.. (2002). Role of the AKT kinase in expansion of multiple myeloma clones: effects on cytokine-dependent proliferative and survival responses. Oncogene. 21(9). 1391–1400. 4 indexed citations
11.
Hsu, Jung-Hsin, Yijiang Shi, Stanisław Krajewski, et al.. (2001). The AKT kinase is activated in multiple myeloma tumor cells. Blood. 98(9). 2853–2855. 163 indexed citations
12.
Hsu, Jung-Hsin & Gregory A. Brent. (1998). Thyroid Hormone Receptor Gene Knockouts. Trends in Endocrinology and Metabolism. 9(3). 103–112. 50 indexed citations
13.
Hsu, Jung-Hsin, Ann Marie Zavacki, John W. Harney, & Gregory A. Brent. (1995). Retinoid-X receptor (RXR) differentially augments thyroid hormone response in cell lines as a function of the response element and endogenous RXR content.. Endocrinology. 136(2). 421–430. 39 indexed citations
15.
Harms, Etti, et al.. (1985). Comparison of the regulatory regions of ilvGEDA operons from several enteric organisms. Journal of Bacteriology. 164(1). 207–216. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026